Table 2.
Baseline and 8-week measurements amongst the study population
| Baseline | Week 8 | |||||||
|---|---|---|---|---|---|---|---|---|
|
|
|
|||||||
| Controla | Fisha | Controla | Fisha | |||||
|
|
|
|
|
|||||
| n | n | n | n | |||||
| Weight (kg) | 37 | 73.8±2.1 | 43 | 75.7±2.2 | 37 | 73.6±2.0 | 43 | 75.8±2.1 |
| BMI (kg/m2) | 37 | 26.4±0.6 | 43 | 26.5±0.6 | 37 | 26.3±0.6 | 43 | 26.5±0.6 |
| Systolic blood pressure (mmHg) | 37 | 126±2 | 43 | 126±2 | 37 | 126±3 | 43 | 124±3 |
| Diastolic blood pressure (mmHg) | 37 | 67±1 | 43 | 69±1 | 37 | 66±1 | 43 | 68±2 |
| CRP (mg/L)b | 37 | 0.8 (0.5, 1.3) | 43 | 1.17 (0.8, 1.8) | 37 | 0.8 (0.5, 1.3) | 43 | 1.0 (0.7, 1.5) |
| IL-1β (pg/ml)b,c | 15 | 6.9 (4.7, 10.1) | 18 | 8.11 (5.3, 12.4) | 15 | 7.7 (6.2, 9.4) | 18 | 7.3 (6.0, 8.8) |
| IL-6 (pg/ml)b,c | 10 | 7.9 (5.4, 11.4) | 11 | 7.21 (5.4, 9.7) | 10 | 7.5 (5.9, 9.6) | 11 | 7.7 ( 5.2, 11.4) |
| Total cholesterol (mmol/L) | 37 | 5.5±0.2 | 43 | 5.5±0.1 | 37 | 5.4±0.2 | 43 | 5.6±0.1 |
| HDL-C (mmol/L) | 37 | 1.6±0.1 | 43 | 1.7±0.1 | 37 | 1.7±0.1 | 43 | 1.8±0.1 |
| LDL-C (mmol/L) | 37 | 3.3±0.1 | 43 | 3.2±0.1 | 37 | 3.2±0.1 | 43 | 3.4±0.1 |
| Triacylglycerol (mmol/L) | 37 | 1.4±0.1 | 43 | 1.1±0.1 | 37 | 1.3±0.1 | 43 | 1.0±0.1 |
BMI: body mass index; CRP: C-reactive protein; IL-1β: interlukin-1 beta; IL-6: interleukin 6; HDL-C: high-density lipoprotein cholesterol; LDL-C: low-density lipoprotein cholesterol.
a
Data reported as mean±standard error of the mean.
b
Data reported as geometric means (95% CI).
c
Values only reported if above limit of detection.